Market Research Report
Australia Alopecia (Hair Loss) Treatment Market Forecast 2021-2026
|Published by||Inkwood Research||Product code||1018676|
|Published||Content info||97 Pages
Delivery time: 2-3 business days
|Australia Alopecia (Hair Loss) Treatment Market Forecast 2021-2026|
|Published: July 19, 2021||Content info: 97 Pages||
The Australia alopecia (hair loss) treatment market is set to record a CAGR of 6.48% during the forecast period, 2021-2026. The increasing internet penetration, unhealthy dietary habits, and sedentary lifestyle propel market growth.
In Australia, as per the Australian Institute of Health and Welfare, 68% of men aged 18 and above are obese, attributed to a high cholesterol diet, which causes hair loss. Also, stress levels are majorly adding to the increasing alopecia cases in females and males. Moreover, organizations like Australia Alpoecia Areata Foundation Inc (AAAF) support people suffering from alopecia through their work and spread disease awareness.
Furthermore, the market growth was influenced by the impact of the pandemic, especially on the proper functioning of the hair care industry in Australia. People prioritized hygiene that boosted the shampoo product demands. In addition, the closure of salons due to lockdown and associated restrictions resulted in companies innovating at-home hair dyes for consumers.
Also, with the increasing number of people gaining awareness about the benefits of organic and natural products, there is a huge demand for natural ingredients. As a result, companies are launching products with nature-inspired ingredients like premium botanical and plant-inspired ingredients. Such factors contribute to market growth in Australia.
Some of the eminent companies in the market include: Teva Pharmaceutical Industries Ltd, Cellmid, Transitions Hair Pvt Ltd, Cipla Limited, Taisho Pharmaceutical Co Ltd, etc.